Nurse Practitioner, Acute Care · New York, NY
NPI
1497923700
Since 2008
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Avenue
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
323 services
Medicare patients, 2024
112
Average age 73
Drug cost, 2024
$618K
179 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marykate Kasler was code 99214 (office e&m - established), 314 times for 111 patients. In total Marykate Kasler billed 323 services in 5 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 314 | 111 | $79.32 | $25K |
By year: 2022 $32K for 433 services; 2023 $31K for 433 services; 2024 $26K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marykate Kasler prescribed most often to Medicare patients was Imatinib Mesylate, with 45 prescriptions and refills. In total Marykate Kasler wrote 179 Medicare prescriptions that cost $618K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 45 | 57 | Under 11 | $66K |
| Sunitinib Malate Generic | 15 | 15 | Under 11 | $152K |
| Ondansetron Hcl Generic | 11 | 11 | Under 11 | $180 |
Brand drugs: 18 claims; generic drugs: 161 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marykate Kasler were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.